Diabetes mellitus affects more than 500 million people worldwide, and both Type 1 (T1D) and Type 2 (T2D) forms converge on a common endpoint: the loss or ...
IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...
Morning Overview on MSN
Baby KJ becomes first human ever treated with a personalized gene-editing therapy
Before Baby KJ was six months old, doctors at Children’s Hospital of Philadelphia injected a gene-editing therapy built for ...
Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike ...
Researchers have introduced 'prime assembly,' a genome editing approach that allows insertion of large DNA segments, enabling entire gene replacements. The method avoids harmful double-strand breaks ...
Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. Additional reporting by Anna Rogers Two years ago, we devoted an entire issue to the ...
A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human body—a key step toward broader clinical use. Researchers identified a ...
Almost as soon as researchers started exploring the capabilities of the CRISPR/Cas9 system, they recognized its potential use in targeted gene editing. But the intervening decades have seen slow ...
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative options. After research conducted as ...
Gene editing tools are powering new innovation in the plant sciences world, but that brings new considerations of intellectual property and regulatory risks. Ever since powerful new gene editing tools ...
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines. The approach, which is ...
CRISPR Therapeutics' gene-editing platform looks fairly promising, but plenty of challenges could sink the stock. Vertex Pharmaceuticals has a robust underlying business along with some exposure to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results